Article

Developing Optimal Formulations Using Biorelevant Predictive Tools And Advanced Bioavailability Enhancement Technologies

By Jennifer Dressman, Professor, University of Frankfurt and Fraunhofer Institute of Translational Medicine and Pharmacology, and Stephen Tindal, Director, Science and Technology, Catalent

GettyImages-157742535-molecule

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

Catalent